Merriman Capital Acted as Co-Manager in Avanir Pharmaceuticals, Inc.'s Follow-on Offering

Merriman Capital, Inc., a wholly owned subsidiary of Merriman Holdings, Inc. MERR, acted as co-manager in Avanir Pharmaceuticals, Inc.'s AVNR $88 million follow-on offering of common stock at $4.40 per share. The transaction closed yesterday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsOfferingsFinancialsHealth CareInvestment Banking & BrokeragePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!